Meet the 2022 Laureates: Henry M. Kronenberg, MD

Kronenberg, Henry (PE 2015)

Henry M. Kronenberg, MD

Fred Conrad Koch Lifetime Achievement Award

Henry M. Kronenberg, MD, has been chief of the Endocrine Unit at Massachusetts General Hospital in Boston, Mass., for over 32 years and is a professor of medicine at Harvard Medical School in Boston, Mass. 

His research group studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis, and the roles of osteoblast-lineage cells in hematopoiesis. His biggest accomplishment is bringing molecular biology to the bone and mineral field with the cloning of the parathyroid hormone. Kronenberg’s laboratory in recent years has used several genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone. 

President of the Endocrine Society from 2016 to 2017, Kronenberg has served on many other Society committees over the years, most notably as vice president, Basic Science, and as the Endocrine Society’s representative on the Federation of American Societies for Experimental Biology (FASEB) Board of Directors. 

How has the Endocrine Society supported your professional development/career journey?

The Endocrine Society was the first national society to welcome me, and, from that beginning, I have relied on the Endocrine Society to make me aware of new ways of thinking about endocrinology, both at the basic and clinical level. The annual meeting and journals, in particular, have defined current endocrinology for me. Equally importantly, the Endocrine Society has been the vehicle for my meeting people in the field from whom I have learned a lot and gained lasting friendships. I have been extremely grateful that the Society has provided me with leadership opportunities that gave me a unique chance to contribute to the broader missions of the Endocrine Society.

As a Laureate Award recipient, do you have any advice for those just beginning their careers?

I think that the key to a satisfying career is finding an area or activity about which you are passionate. As I started my career, I was amazed by the discovery of how hormones could control gene regulation in molecular detail. I badly wanted a chance to study this process, and I continue to be as excited now as I was then at the chance to participate in that effort.  If your job is to do what you love to do, then you’ve chosen the right career.  For me, the chance to combine endocrine research with the care of patients with hormone problems combines that passion for discovery with the sense of fulfillment that comes from trying to help others.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…